Akero Therapeutics, Inc.

NasdaqGS:AKRO Stock Report

Market Cap: US$2.3b

Akero Therapeutics, Inc. Company Information

Akero Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Akero Therapeutics, Inc.
  • Ticker: AKRO
  • Exchange: NasdaqGS
  • Founded: 2017
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$2.285b
  • Shares Outstanding: 69.80m
  • Website: https://akerotx.com

Number of Employees

Location

  • Akero Therapeutics, Inc.
  • 601 Gateway Boulevard
  • Suite 350
  • South San Francisco
  • California
  • 94080
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AKRONasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDJun 2019
0K4DB (Deutsche Boerse AG)YesCommon StockDEEURJun 2019

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/24 11:41
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.